๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Normal Subjects

A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases NCT06978647Phase 11 site๐Ÿ“ Beijing China Immunotech (Beijing) Biotechnology Co., Ltd. ยท Tests: YTS109 cell Testing Use of Topical Imipramine in Reducing Ultraviolet B Induced Microvesicle Particle Release in Photosensitive Subjects NCT04520217Phase 11 site๐Ÿ“ Fairborn Wright State University ยท Tests: 4% Imipramine Cream, Base Cream A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis NCT06972446Phase 296 sites๐Ÿ“ Peoria๐Ÿ“ Jonesboro๐Ÿ“ Beverly Hills AbbVie ยท Tests: Lutikizumab, Placebo, Ravagalimab FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer NCT05304962Phase 18 sites๐Ÿ“ La Jolla๐Ÿ“ Los Angeles๐Ÿ“ Port Saint Lucie Regor Pharmaceuticals Inc. ยท Tests: RGT-419B, RGT-419B in combination with hormonal therapy A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) NCT06330064Phase 1, Phase 2120 sites๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles๐Ÿ“ Whittier Daiichi Sankyo ยท Tests: Ifinatamab deruxtecan Participants with Mild to Moderate Hidradenitis Suppurativa Will Receive EVO101 a Topical Cream 0.1% NCT06645821EARLY Phase 11 site๐Ÿ“ Norfolk Virginia Clinical Research, Inc. ยท Tests: EVO101 Effect of Adding Thoracolumbar Fascia Release by IASTM to Conventional Treatment on Craniovertebral Angle in Forward Head Subjects NCT07605650NA1 site๐Ÿ“ Giza Cairo University ยท Tests: Instrument assisted soft tissue moblization Investigation of Neurovascular Coupling in Glaucoma Patients and Healthy Subjects NCT03870230NA1 site๐Ÿ“ Vienna Medical University of Vienna ยท Tests: Fourier Domain Doppler Optical Coherence Tomography (FDOCT), Dynamic Vessel Analyzer (DVA), Pattern Electroretinographyโ€ฆ A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1) NCT06557265Phase 1, Phase 219 sites๐Ÿ“ Little Rock๐Ÿ“ Tustin๐Ÿ“ Gainesville Nkarta, Inc. ยท Tests: NKX019, Fludarabine, Cyclophosphamide Safety, Tolerability, and Pharmacokinetics of Single Doses of HC022 in Healthy Subjects. NCT06657703Phase 13 sites๐Ÿ“ Beijing๐Ÿ“ Beijing๐Ÿ“ Beijing HC Biopharma Inc. ยท Tests: HC022, Placebo A Study of GB491 in Combination With Letrozole in Patients With HR Positive and HER2 Negative Advanced Breast Cancer NCT05851014Phase 352 sites๐Ÿ“ Bengbu๐Ÿ“ Hefei๐Ÿ“ Hefei Genor Biopharma Co., Ltd. ยท Tests: GB491 combined with Letrozole, Placebo combined with Letrozole A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study NCT04641247Phase 225 sites๐Ÿ“ Tucson๐Ÿ“ Encinitas๐Ÿ“ Los Angeles GlaxoSmithKline ยท Tests: Niraparib Assessing and Improving Quantitative Magnetic Resonance Imaging Metrics in Human Subjects NCT05604534n/a1 site๐Ÿ“ Bethesda National Institute of Neurological Disorders and Stroke (NIโ€ฆ Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma NCT05489887Phase 226 sites๐Ÿ“ Birmingham๐Ÿ“ Little Rock๐Ÿ“ Oakland Giselle Sholler ยท Tests: Naxitamab A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque Psoriasis NCT04772079Phase 365 sites๐Ÿ“ Ciudad Autonoma de Buenos Aires๐Ÿ“ Ciudad Autonoma de Buenos Aires๐Ÿ“ Buenos Aires Bristol-Myers Squibb ยท Tests: Deucravacitinib, Placebo matching deucravacitinib Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With Glioblastoma NCT05083754Phase 11 site๐Ÿ“ Baltimore Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ยท Tests: Retifanlimab, Temozolomide, Radiation Therapy A Study to Test the Repeatability and Reproducibility in Rod Intercept Time Within the AdaptDx Pro in Healthy Subjects With Normal Vision (FlashForward) NCT07860905n/a1 site๐Ÿ“ Silverdale AdaptDx, Inc. ยท Tests: AdaptDx Pro A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors NCT05970497Phase 1, Phase 215 sites๐Ÿ“ Los Angeles๐Ÿ“ Rancho Santa Margarita๐Ÿ“ Weston Krystal Biotech, Inc. ยท Tests: KB707, Opdualag, KEYTRUDA ยฎ( Pembrolizumab) A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases NCT07104721Phase 11 site๐Ÿ“ Hefei China Immunotech (Beijing) Biotechnology Co., Ltd. ยท Tests: YTS109 cell Analysis of 18F-XTR006 PET Imaging in Cognitively Normal Subjects, and Patients With MCI and AD NCT07115238Phase 31 site๐Ÿ“ Beijing Sinotau Pharmaceutical Group ยท Tests: XTR006 Bedside Bone Biopsy in Diabetic Foot Osteomyelitis NCT06066801NA1 site๐Ÿ“ Paris Assistance Publique - Hรดpitaux de Paris ยท Tests: Bedside blind bone biopsy procedure Evaluate the Concordance Between PET Imaging of [18F]-APN-1607 Injection and Postmortem Brain Tissue Tau Pathology in Individuals With HV and MCI or AD. NCT07752784Phase 31 site๐Ÿ“ Beijing JYAMS PET Research & Development Limited ยท Tests: [18F]-APN-1607 A Multicenter, Randomized, Double-blind, Vehicle Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 Gel in Adult Subjects With Mild to Moderate Atopic Dermatitis NCT07598383Phase 21 site๐Ÿ“ Hangzhou Jiangsu vcare pharmaceutical technology co., LTD ยท Tests: VC005 group, VC005 Placebo group ICP-332 in Subjects With Moderate to Severe Atopic Dermatitis NCT06775860Phase 362 sites๐Ÿ“ Hefei๐Ÿ“ Wuhu๐Ÿ“ Beijing Beijing InnoCare Pharma Tech Co., Ltd. ยท Tests: ICP-332 Tablets, ICP-332 Placebo Tablets Efficacy and Safety Study of Disitamab Vedotin + RC148 vs. Albumin-Paclitaxone ยฑ Toripalimab in HR-/HER2-low Breast Cancer NCT06642545Phase 21 site๐Ÿ“ Beijing RemeGen Co., Ltd. ยท Tests: Disitamab Vedotin, RC148, Albumin-bound Paclitaxone, Toripalimab Diet Restiction in Subjects With Behcet Disease and Complaint of Tinnitus NCT07702149NA2 sites๐Ÿ“ Giza๐Ÿ“ Dokki Cairo University ยท Tests: diet restriction A Study to Evaluate Efficacy and Safety of Light Dose in Subjects With PWB Treated With Hemoporfin PDT NCT05171894Phase 25 sites๐Ÿ“ Irvine๐Ÿ“ San Diego๐Ÿ“ Miami Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. ยท Tests: Hemopfin+Green Light, Vehicle+Green Light A Study to Evaluate the Efficacy and Safety of SHR-1703 in Subjects With Eosinophilic Granulomatosis With Polyangiitis ๏ผˆEGPA๏ผ‰ NCT05979051Phase 2, Phase 32 sites๐Ÿ“ Beijing๐Ÿ“ Hangzhou Guangdong Hengrui Pharmaceutical Co., Ltd ยท Tests: SHR-1703, Mepolizumab Injection Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS) NCT03016819Phase 324 sites๐Ÿ“ Phoenix๐Ÿ“ Los Angeles๐Ÿ“ Santa Monica Advenchen Laboratories, LLC ยท Tests: AL3818, Dacarbazine, AL3818 or placebo, Midazolam 2 mg for CYP3A4 phenotyping, Digoxin (0.25mg) Positron Emission Tomography (PET) Imaging of Cholesterol Trafficking: Clinical Evaluation of [18F]FNP-59 in Normal Human Subjects (Group 1) NCT04532489EARLY Phase 11 site๐Ÿ“ Ann Arbor Benjamin Viglianti ยท Tests: FNP-59
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy